










































Autocrine androgen action is essential for Leydig cell maturation
and function, and protects against late-onset Leydig cell
apoptosis in both mice and men
Citation for published version:
O'Hara, L, McInnes, K, Simitsidellis, I, Morgan, S, Atanassova, N, Slowikowska-Hilczer, J, Kula, K, Szarras-
Czapnik, M, Milne, L, Mitchell, RT & Smith, LB 2014, 'Autocrine androgen action is essential for Leydig cell
maturation and function, and protects against late-onset Leydig cell apoptosis in both mice and men' The
FASEB Journal, vol. 29, no. 3, pp. 894-910. DOI: 10.1096/fj.14-255729
Digital Object Identifier (DOI):
10.1096/fj.14-255729
Link:
Link to publication record in Edinburgh Research Explorer
Document Version:




This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 International
(CCBY 4.0) (http://creativecommons.org/licenses/by/4.0/) which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
General rights
Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s)
and / or other copyright owners and it is a condition of accessing these publications that users recognise and
abide by the legal requirements associated with these rights.
Take down policy
The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer
content complies with UK legislation. If you believe that the public display of this file breaches copyright please
contact openaccess@ed.ac.uk providing details, and we will remove access to the work immediately and
investigate your claim.
Download date: 05. Apr. 2019
The FASEB Journal • Research Communication
Autocrine androgen action is essential for Leydig cell
maturation and function, and protects against
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ABSTRACT Leydig cell number and function decline as
men age, and low testosterone is associated with all
“Western” cardio-metabolic disorders. However, whether
perturbed androgen action within the adult Leydig cell
lineage predisposes individuals to this late-onset de-
generation remains unknown. To address this, we gener-
ated a novel mouse model in which androgen receptor
(AR) is ablated from ∼75% of adult Leydig stem cell/cell
progenitors, from fetal life onward (Leydig cell AR
knockout mice), permitting interrogation of the speciﬁc
roles of autocrine Leydig cell AR signaling through com-
parison to adjacent AR-retaining Leydig cells, testes from
littermate controls, and to human testes, including from
patients with complete androgen insensitivity syndrome
(CAIS). This revealed that autocrine AR signaling is dis-
pensable for the attainment ofﬁnal Leydig cell numberbut
is essential for Leydig cell maturation and regulation of
steroidogenic enzymes in adulthood. Furthermore, these
studies reveal that autocrine AR signaling in Leydig cells
protects against late-onset degeneration of the seminifer-
ous epithelium inmice and inhibits Leydig cell apoptosis in
both adult mice and patients with CAIS, possibly via op-
posing aberrant estrogen signaling. We conclude that
autocrine androgen action within Leydig cells is essential
for the lifelong support of spermatogenesis and the
development and lifelong health of Leydig cells.—O’Hara,
L., McInnes, K., Simitsidellis, I., Morgan, S., Atanassova,
N., Slowikowska-Hilczer, J., Kula, K., Szarras-Czapnik,
M., Milne, L., Mitchell, R. T., Smith, L. B. Autocrine
androgen action is essential for Leydig cell maturation
and function, and protects against late-onset Leydig cell
apoptosis inbothmiceandmen.FASEB J.29, 894–910 (2015).
www.fasebj.org
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MALE HEALTH AND WELL-BEING are androgen dependent. Re-
duced androgen action is associated with many in-
creasingly prevalent chronic and age-related clinical
conditions, including cardiovascular disease (1), diabetes,
obesity, andmetabolic syndrome (2–5), and is a predictor
of early death (6, 7). The testicular Leydig cells produce
the vast majority of androgens in men and, as such, are
a key driver of men’s health. Once established, the adult
Leydig cells are maintained as a stable, terminally differ-
entiated population with little evidence of cell turnover
throughout the majority of adulthood (8). However, men
experience both a reduction in Leydig cell number (9, 10)
and reduced testosterone (T) production per Leydig cell
(11) as they age, but theunderlying cause for this is unclear.
The trophic functions of androgens are largely medi-
ated throughout the body by binding the androgen re-
ceptor (AR), amember of the nuclear receptor superfamily
of ligand-activated transcription factors. Fetal Leydig cells
Abbreviations: Adipo-ARKO, adipocyte androgen receptor
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donot expressAR(12); however, adultLeydig cells acquire
AR expression and thus become responsive to autocrine
androgen signaling at their stem/progenitor cell stage (in
fetal life) (13). Why autocrine androgen signaling is re-
quired in stem/progenitor adult Leydig cells is unknown,
but the presence of AR in these cells in fetal life could
provide a mechanistic explanation as to why aberrant an-
drogen action in fetal life predicts lower T levels and re-
duced androgen action in adulthood (14, 15). Indeed,
recent data from our group support the notion that an-
drogenic programming of adult Leydig stem cell/cell
progenitors may have lifelong consequences (16).
Leydig cell androgen signaling has been postulated
to be essential for the development of fully functional
adult Leydig cells, speciﬁcally controlling their ﬁnal
number, their steroidogenic enzyme expression, and
the maturation stage they reach (17). Hypotheses
concerning the autocrine role of AR in Leydig cells
have largely been formulated through studies using an
AR null testicular feminization mouse (Tfm) (18).
Leydig cell number in the Tfm is 60% controls (19),
associated with a signiﬁcant reduction in T production
despite high levels of circulating LH (20, 21), which
implies that steroidogenic enzyme expression is also
altered. Indeed, transcript levels of several steroido-
genic enzymes are almost absent in the Tfm testis (19).
These changes in transcription are supported by
observations of CYP17A1 and HSD17B enzyme activity,
which are also both markedly reduced in the Tfm testis
(20, 22). Several lines of evidence arising from the Tfm
studies point to the importance of Leydig cell AR signaling
in the maturation of Leydig cells to the adult Leydig cell
stage. Gene expression of speciﬁc transcripts associated
with fullymature adult Leydig cells, including Insl3,Hsd3b6,
and Ptgds, is absent inTfm testes (19). Furthermore, Leydig
cells in the Tfm display prominent lipid droplets that are
characteristic of immature adult Leydig cells, and the in-
crease in smooth endoplasmic reticulum associated with
normal Leydig cell maturation is absent (22).
However, the use of the Tfmmodel to delineate the role
of AR in Leydig cells is complicated both by the effects of
the absence of AR in other cells in the testis and the
hypothalamic-pituitary-gonadal axis, and also the impacts
of cryptorchidism associated with the Tfm mutant, which
leads to temperature-induced degenerative effects (23).
Conditional gene targeting has provided novel insights
into the impact of AR signaling inmultiple cell types within
the male reproductive system (24–31) by circumventing
the compounding effects associated with global ablation of
AR function seen in the Tfm (32). A previous attempt to
create aLeydig cell androgen receptor knockout (LCARKO)
mouse using the Cre-LoxP system utilized AMHR2-Cre to
drive AR ablation (33). These mice demonstrated a re-
duction in T secretion and testicular size and spermato-
genic arrest at the round spermatid stage leading to
infertility.However, becauseAMHR2-Cre also functions in
Sertoli cells (34), the contributionofARablation inSertoli
cells to the overall phenotype makes it challenging to
dissect the role that Leydig cell ARplays in this phenotype.
To establish the role of AR in the adult Leydig cell
lineage, we generated a novel mouse model in which AR
is ablated from ;75% of adult Leydig stem cell/cell
progenitors, from fetal life onward (LCARKO mice),
permitting interrogationof the speciﬁc roles of autocrine
Leydig cell AR signaling through comparison to adjacent
AR-retaining Leydig cells, testes from littermate controls,
and to normal human testes and those from patients with
complete androgen insensitivity syndrome (CAIS), arising
throughmutation of AR. These analyses both conﬁrm and
refute some of the previously ascribed roles to AR in adult
Leydig cells and reveal a previously unattributed role for
autocrine AR signaling within developing Leydig cells
essential for retention of the Leydig cell population in
adulthood in both mice and humans. We conclude that
autocrine androgenactionduringLeydig cell development
is essential for the lifelong support of spermatogenesis and
health of the Leydig cell population in adult males.
MATERIALS AND METHODS
Ethics statement
The ethics approval for human testicular biopsies was obtained
from the Bioethics Committee at theMedical University of Lodz,
Poland(referencenumberRNN/28/10/KE).Allmicewerebred
under standard conditions of care and use under licensed ap-
proval from the UK Home Ofﬁce (60/4200).
Lineage tracing of adult Leydig stem/progenitor cells
MalecongenicC57BL/6Jmicehemizygous foraFattyAcidBinding
Protein 4 (Fabp4)-Cre transgene (35) were mated to homozygous
R26R-EYFP females (36). The +/Fabp4-Cre;+/R26R-EYFP and +/+;
+/R26R-EYFP (control) male offspring from these matings were
genotyped as previously described (30). Freshly dissected organs
were visualized with a Leica MZFLIII microscope (Wetzlar,
Germany) and an epiﬂuorescent yellow ﬂuorescent protein
(YFP) ﬁlter. Photographs were taken with a CoolSNAP camera
andPMCapturePro6.0 software(Photometrics,Tucson,AZ,USA).
Targeted ablation of AR from Leydig cells using
Fabp4-Cre mice
Mice in which AR has been ablated selectively from Leydig cells
were generated using Cre/loxP technology. Male congenic
C57BL/6J mice carrying a random insertion of Fabp4-Cre (35)
were mated to C57BL/6J female mice homozygous for a ﬂoxed
AR (24). The +/Cre;ARﬂox/y male offspring from these matings
were termed “LCARKO,” whereas the +/+;ARﬂox/y littermates
were used as controls, termed “control.” +/Cre mice were also
generated by mating Fabp4-Cre stud males to C57BL/6J females
to conﬁrm that expression of Cre alone did not induce a pheno-
type. Mice in which AR has been selectively ablated from adipo-
cytes were generated by mating male congenic C57BL/6J mice
hemizygous for a targeted insertion of Cre recombinase down-
streamof theadiponectin start codon(37) tohomozygous female
ARﬂox mice. The +/Cre;ARﬂox/y male offspring from these mat-
ings were termed “Adipo-ARKO.” Mice in which AR has been
ablated from all cells were generated by mating male congenic
129S1/SvImJ mice hemizygous for a targeted insertion of Cre
recombinase at the ubiquitously expressed hypoxanthine phos-
phoribosyltransferase locus (38) to homozygous female ARﬂox
mice, as described previously (39). The +/Cre;ARﬂox/y male
(continued from previous page)
human chorionic gonadotropin; HSD3B, 3b-hydroxysteroid
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tion mouse; YFP, yellow ﬂuorescent protein
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offspring from these matings were termed “ARKO.” Sex and ge-
notype ratios were all identiﬁed at theexpectedMendelian ratios.
PCR genotyping of mice
Mice were genotyped for the inheritance of Cre recombinase as
previously described (30). PCR ampliﬁcation products were re-
solved using a QIAxcel capillary system (QIAGEN, Crawley,
United Kingdom). An amplicon of 324 bp acted as a positive in-
ternal control, whereas an amplicon of 102 bp indicated the in-
heritance of the Cre recombinase transgene.
Recovery of reproductive tissues
Micewere culled by inhalation of carbon dioxide and subsequent
cervicaldislocation(adults)ordecapitation(neonates). Ifhuman
chorionic gonadotropin (hCG) stimulation of Leydig cells was
required, mice were injected s.c. with a single 20 IU dose of hCG
(Pregnyl;Organon,Oss,TheNetherlands), thenculled16h later.
Body weight and anogenital distance were measured, and mice
were examined for any gross abnormalities of the reproductive
system. Testes and seminal vesicles were removed and weighed.
Tissues were ﬁxed in Bouin’s ﬁxative (Clin-Tech, Guildford,
UnitedKingdom) for 6 h. Bouin-ﬁxed tissues were processed and
embedded in parafﬁn wax, and 5 mm sections were used for his-
tologic analysis as reported previously (30). Sections of testis were
stained with hematoxylin and eosin using standard protocols and
examined for histologic abnormalities.
Immunohistochemistry
Immunolocalization was performed by a single-antibody colori-
metric 3,39-diaminobenzidine (DAB) immunostaining method,
asdescribedpreviously (27), a single- or double-antibody tyramide
ﬂuorescent immunostaining method, as described previously
(26, 40), or an automated Bond immunostaining method, as
described previously (27, 40). Antibodies used are listed in
Table 1. A minimum of 5 individual sections for each age and
genotype were immunostained in each experiment.
Determination of testicular Leydig cell composition
Standard stereologic techniques involving point counting of cell
nuclei were used to determine the nuclear volume per testis of
eachpopulation of Leydig cells, namely normal adult Leydig cells
positive for 3b-hydroxysteroid dehydrogenase (HSD3B), as de-
scribed previously (24, 30). Data were used to determine the
nuclear volumeandnumber of Leydig cells per testis. Testes from
a minimum of 4 individuals were counted for each group.
Determination of testicular germ cell composition
Standard stereologic techniques involving point counting of cell
nuclei were used to determine the nuclear volume per testis of
spermatogonia, spermatocytes, and spermatids as described
previously (24). Testes from a minimum of 4 individuals were
counted for eachgroup.Datawereused todetermine thenuclear
volume per testis of each type of germ cell.
Quantiﬁcation of AR ablation in Leydig cells
For the quantiﬁcation of AR ablation in Leydig cells of control
and LCARKO mouse testes (n = 4 for each group), double-
immunoﬂuorescence detection was performed for AR and
HSD3B as described above, and the sections were tiled using the
Zeiss LSM 510Meta Axiovert 100M confocal microscope and the
Zen2011 software (both fromCarl Zeiss Limited,WelwynGarden
City, United Kingdom). The whole-testis images were then pro-
cessed with the Image-Pro Plus 6.2 software (Media Cybernetics
U.K., Berkshire, United Kingdom) to quantify AR ablation in
Leydig cells. Cells demonstrating .50% HSD3B staining sur-
rounding their nucleus were considered Leydig cells, and those
with green-stained nuclei were counted as AR-positive Leydig
cells, whereas those with blue-stained nuclei were considered to
have AR ablation.
Quantiﬁcation of Leydig cell apoptosis
For thequantiﬁcationof apoptosis in theLeydig cells of 80- to 100-
d-old and 6- to 9-mo-old LCARKO mouse testes (n = 4 for each
group), immunohistochemistry for cleaved caspase-3 (CASP3)
(as described in Table 1) was performed. No Leydig cell-cleaved
caspase staining could be seen in testis sections from control
animals, so these were not quantiﬁed. Sections were analyzed
using Image-Pro Plus 6.2 software with a Stereology 5.0 plug-in
(Media Cybernetics U.K.) using the 363 objective on a Leitz
DMRB microscope (Wetzlar, Germany) ﬁtted with a Prior Pro-
Scan automatic stage (Prior Scientiﬁc Instruments Limited,
Cambridge, United Kingdom). TheCount (NV) setting was used
to count all cells with Leydig cell morphology staining either
positive or negative for cleaved caspase, and these ﬁgures were
expressed as a percentage.
Determination of genomic ablation of AR
DNA was isolated from a piece of frozen testis using a Mouse
Tail Genomic DNA kit (Gen-Probe Life Sciences Limited,
Manchester, United Kingdom) according to themanufacturer’s
instructions and subjected to PCR ampliﬁcation using primers
59-GCTGATCATAGGCCTCTCTC-39 and 59-TGCCCTGAAAG-
CAGTCCTCT-39 asdescribedpreviously (26). PCRampliﬁcation
products were resolved using a QIAxcel capillary system. An
amplicon of 1142 bp indicated the presence of a ﬂoxed AR,
whereas an ampliconof 612bp indicated recombinationbetween
loxP sites and deletion of AR exon 2.
Quantitative RT-PCR
RNA was isolated from frozen testes from 8, 80-d-old LCARKO
and 8 control mice, or 6 Adipo-ARKO or 6 control mice, using
theRNeasyMini extraction kit with RNase-free DNase on the col-
umn digestion kit (QIAGEN) according to the manufacturer’s
instructions. For quantitative RT-PCR, 5 ng Luciferase mRNA
(Promega Corporation, Madison, WI, USA) was added to each
testis sample before RNA extraction as an external standard (41).
RNA was quantiﬁed using a NanoDrop 1000 spectrophotometer
(Thermo Fisher Scientiﬁc, Waltham, MA, USA). Random
hexamer-primed cDNA was prepared using the SuperScript
VILO cDNA Synthesis Kit (Life Technologies, Grand Island, NY,
USA) according to the manufacturer’s instructions. Quantitative
PCR was performed on 80-d-old LCARKO and control testes for
the genes listed in Table 2, using an ABI Prism 7900 Sequence
Detection System (AppliedBiosystems, Foster City, CA,USA)and
theRocheUniversal Probe library (Welwyn,UnitedKingdom), as
described previously (30). The expression of each gene was re-
lated to an external positive control luciferase, as published pre-
viously (42), and all genes were expressed per testis.
Extraction of steroid hormones from testis and plasma
Immediately after culling, blood was collected from control and
LCARKO mice by cardiac puncture with a syringe and needle
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pretreated with heparin. Plasma was separated by centrifugation
and stored at280°C. Testes were weighed, cut in half, and then
snap-frozen on dry ice. Steroids were diethylether extracted from
the testis lysate or plasma, dried under a constant stream of ni-
trogen, and then resuspended in the appropriate kit buffer.
Quantiﬁcation of hormone levels
T was measured using an ELISA kit (DEV9911; Demeditec
Diagnostics, Kiel, Germany) according to the manufacturer’s
instructions. Estradiol was measured using a mouse/rat estradiol
ELISA kit (ES180S-100; Calbiotech, Spring Valley, CA, USA),
which has been shown to provide good correlation to GC-MSMS-
derived values (43) according to themanufacturer’s instructions.
Progesterone was measured using a mouse progesterone ELISA
kit (CSB-E05104m; Cusabio Biotech Company, Hubei Province,
People’s Republic of China) according to the manufacturer’s
instructions. LH and FSH were measured using in-house-
designed ELISAs as previously described (44). All samples were
run in a single assay for each hormone.
Western blotting
Western blotting for CYP19A1 and ESR1 was performed as
reportedpreviously (45) on 80-d-old control andLCARKO testes.
Blots were probed with primary antibodies ESR1 (sc-542; Santa
Cruz Biotechnology, Dallas, TX, USA) and tyrosinated TUBA
(a-tubulin) isoforms (ab6160; Abcam, Cambridge, MA, USA) or
CYP19A1 [aromatase (Arom), ab18995; Abcam] and glyceralde-
hyde 3-phosphate dehydrogenase (GAPDH) (ab9486; Abcam).
TABLE 1. Immunohistochemistry performed in this study, listing antibody source and method used
Protein stained for Method Primary antibodies
HSD3B/YFP Double ﬂuorescence HSD3B: Santa Cruz Biotechnology
#sc30820
YFP: Life Technologies #A-11122
HSD3B/AR Double ﬂuorescence HSD3B: Santa Cruz Biotechnology
#sc30820
AR: Abcam #ab74272
HSD3B DAB Santa Cruz Biotechnology #sc30820
INSL3 Bond Gift from Steven Hartung
HSD17B3 DAB HSD17B3: Santa Cruz Biotechnology
#sc-135044
HSD17B3/AR Double ﬂuorescence HSD17B3: Santa Cruz Biotechnology
#sc-135044
AR: Abcam #ab74272
CYP17A1/AR Double ﬂuorescence CYP17A1: Santa Cruz Biotechnology
#sc30820
AR: Abcam #ab74272
CASP3 DAB Cell Signaling (New England BioLabs)
#96615
CASP3/AR Bond CASP3: Abcam #ab4051
AR: Abcam #ab74272
ESR1 Single ﬂuorescence Santa Cruz Biotechnology #sc542
Pan-laminin Bond Abcam #ab11575
ACTA2 Bond Sigma-Aldrich #A-2547
DES Bond Dako #M-0760
CDKN1B DAB Novacastra #NCL-p27
TABLE 2. Quantitative RT-PCR assays used, with sequences of primers and UPL probe numbers
for each assay
Transcript 59 Primer 39 Primer
Roche
UPL probe
Hsd3b6 accatccttccacagttctagc acagtgaccctggagatggt 95
Ptgds ggctcctggacactacaccta atagttggcctccaccactg 89
Insl3 aagaagccccatcatgacct tttatttagactttttgggacacagg 10
Cyp17a1 catcccacacaaggctaaca cagtgcccagagattgatga 67
Hsd17b3 aatatgtcacgatcggagctg gaagggatccggttcagaat 5
Hsd3b1 gaactgcaggaggtcagagc gcactgggcatccagaat 12
Cyp11a1 aagtatggccccatttacagg tggggtccacgatgtaaact 104
Cyp19a1 gagagttcatgagagtctggatca catggaacatgcttgaggact 55
Sult1e1 gaagaacaatccatccaccaat tctgggaagtggttcttcca 6
Esr1 tgcaatgactatgcctctgg ttgtagctggacacatgtagtcatt 93
Gas6 gcttctgctgctcctgct gcctcctcgaagacttggta 27
Pgr tgcacctgatctaatcctaaatga ggtaaggcacagcgagtagaa 17
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Primary antibodies were detected using either donkey anti-rabbit
IRDye 680RD andgoat anti-rat IRDye 800CWor donkey anti-goat
IRDye 680RD and donkey anti-rabbit IRDye 800CW (all LI-COR
Biosciences, Lincoln, NE, USA). Detection was carried out using
the LI-COR Odyssey imaging system (LI-COR Biosciences)
according to the manufacturer’s instructions.
Bioinformatic investigation for evidence of direct
AR regulation
Information about the genesHsd3b1,Hsd17b3, and Cyp11a1 and
mRNA was obtained from theNational Center for Biotechnology
Information (http://www.ncbi.nlm.nih.gov/), and genomic
DNA sequence was retrieved using the Evolutionary Conserved
Regions’ browser (http://ecrbrowser.dcode.org/). The pro-
moter and transcriptional start site for eachgenewas foundusing
the Cold Spring Harbor Transcriptional Regulatory Element
database (http://rulai.cshl.edu/cgi-bin/TRED/tred.cgi?process=
home). Sequences, 3–7 kb upstream of the transcriptional start
site and 3–5 kb 39 of the translational stop codon, were then
manually searched for putative androgen response element
sequences and scored relative to the consensus sequence
AGAACA/TnnnA/TGT/AA/GCT/A/C (weighting given to
positions) [see (46, 47)].
Statistical analysis
Data were analyzed using GraphPad Prism (version 5; GraphPad
Software Incorporated, San Diego, CA, USA) using a 2-tailed
unpaired t test (if comparing 2 groups), a 1-way ANOVA with
Bonferroni post hoc test (if comparing .2 groups). Values are
expressed as mean6 SEM.
RESULTS
Identiﬁcation of Leydig cell-speciﬁc Cre recombinase
To permit targeting of Leydig cell AR, testes from sev-
eral Cre recombinase transgenic mouse lines bred to a
Figure 1. Localization and onset of Fabp4-Cre recombination. A) Fabp4-Cre activates YFP expression in the interstitial cells of an
adult Fabp4-YFP testis. B) All YFP-expressing cells (green) in Fabp4-YFP testes are HSD3B-positive Leydig cells (red), but some
Leydig cells do not express YFP. Scale bars, 50 mm. C) YFP staining in d 0 Fabp4-YFP testis is present in a population of peritubular
cells. Scale bar, 50 mm. D) Genomic recombination of AR (indicated by a 612 bp band) occurs in a population of the cells of the
d 0 LCARKO; another population of cells has unrecombined AR (1142 bp). Genomic AR in control testes is not recombined, and
all genomic AR in ARKO testis is recombined. E) All HSD3B-positive cells (red) in d 21 control testis are positive for AR (green,
arrowhead). Most HSD3B-positive cells in d 21 LCARKO testis are negative for AR (chevrons), but a small population are positive
(arrowhead). Sertoli cells (X) and PTM cells (arrows) are positive for AR in both control and LCARKO. Scale bars, 20 mm. F)
When quantiﬁed, 97% of Leydig cells in d 21 control testis are positive for AR; this was signiﬁcantly decreased in d 21 LCARKO
testis (27%; ****P , 0.0001). Of Leydig cells in d 35 control testis, 83% are positive for AR; this is also signiﬁcantly decreased in
d 35 LCARKO testis (27%; ****P , 0.0001).
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Cre-inducible YFP reporter gene [R26R-EYFP (36)] were
screened for localization of testicular YFP expression
(Supplemental Table S1). One line, in which Cre recom-
binase is driven by the promoter of Fabp4 (previously
known as aP2) (35), displayed Leydig cell-speciﬁc expres-
sionof YFPatd75(Fig. 1A,B). Subsequent interrogationof
Fabp4-Cre+/2;R26R-EYFP+/2 testes at d 0 revealed that the
Cre recombinase ﬁrst functions in the adult Leydig stem/
progenitor cells, prior to the initiation of adult Leydig cell
development (48) (Fig. 1C). Although fetal Leydig cells do
not express AR (12), adult Leydig cells acquire AR ex-
pression at the stem/progenitor cell stage (13), and an-
drogen signalinghasbeenpostulated tobeessential for the
development of fully functional adult Leydig cells, speciﬁ-
cally controlling their ﬁnal number, their steroidogenic
enzyme expression, and the maturation stage they reach
(17). We concluded that this line would permit speciﬁc
ablation of AR from the adult Leydig cell population from
the stem/progenitor cell stage onward.
Generation of LCARKO mice
Testicular histology of hemizygous Fabp4-Cre males was
normal when examined at d 365, conﬁrming that the Cre
recombinase transgene itself had no impact on testis
function (Supplemental Fig. S1A). Male Fabp4-Cre+/2
mice were mated to female mice homozygous for a ﬂoxed
allele of X-linked AR (ARﬂ/ﬂ) (24) to generate LCARKO
mice (Fabp4-Cre+/2;ARﬂ/y) and male littermates (Fabp4-
Cre2/2;ARﬂ/y), which were used as controls throughout
the study. Consistent with the ontogeny of Fabp4-Cre
recombinase expression, LCARKO mice display evidence
of AR DNA recombination within the testis when exam-
ined at d 0 (Fig. 1D). Subsequent immunohistochemical
localization of AR protein conﬁrmed that the loss of AR is
restricted to the developing adult Leydig cell population
(Fig. 1E); AR protein is retained in all other AR-expressing
testicular cell types. Quantiﬁcation of the number of de-
veloping adult Leydig cells expressing AR showed the loss
of AR expression from approximately 75% of adult Leydig
cells, which remained consistent when quantiﬁed at d 21
and 35 (Fig. 1F). Although initially thought to be a poten-
tially confounding factor for downstream interpretation of
results, the 25% of adult Leydig cells retaining AR protein
meant that this model in fact provided a unique opportu-
nity todetermine the rolesof autocrineAR signalingwithin
Leydig cells in vivo because it permits comparison of adja-
cent Leydig cells, all exposed to the same endocrine and
paracrine environment, with one difference: retention or
absence of Leydig cell AR.
LCARKO testes develop normally but display
progressive testicular degeneration
Having validated the generation of a LCARKOmodel, we
next characterized the impact of the loss of Leydig cell AR
on testicular architecture. Testes weight did not differ be-
tween LCARKO mice and control littermates when ex-
amined at d 21 or 35. However, a signiﬁcant reduction in
testis weight in LCARKO mice is observed at d 80 and at
6 mo (approximately d 180) (Fig. 2). Consistent with testis
weight data, examination of testicular histology shows no
apparent difference in testicular architecture between
controls andLCARKOatd21and35(Fig. 3A,B).CDKN1B
staining is present in Sertoli cells in both control and
LCARKO testes and ACTA2 (a-SMA) and pan-laminin
staining in peritubular myoid (PTM) cells in both controls
and LCARKO testes, demonstrating that these cells had
matured appropriately (Supplemental Fig. S2). Although
localization of the PTM intermediate ﬁlament protein
desmin (DES) is interrupted in 80-d-old LCARKOs, sug-
gesting that thismay be an early effect of ablation of Leydig
cell AR on PTM cell function. The ﬁrst wave of spermato-
genesis occurred normally, and all germ cell types are
present. At d 80, testicular histology is normal in controls,
but in the LCARKO, whereas much of the testis appears
normal, localized seminiferous epitheliumdegeneration is
observed at several foci throughout the testis (Fig. 3C). By
6 mo of age, seminiferous epithelium degeneration has
become more widespread in LCARKO testes, whereas
histology remains normal in 6-mo-old controls (Fig. 3D).
Spermatogenesis is quantitatively reduced from d 35
Consistent with the late-onset epithelial degeneration,
quantiﬁcation of testicular cell numbers at d 21, 35, and 80
shows no signiﬁcant difference in Sertoli or spermatogo-
nial cell number (data not shown); however, a small but
statistically signiﬁcant reduction in spermatocyte (Fig. 3E)
and spermatid (Fig. 3F) number is observed at d 35 and 80,
suggesting that the ability of the testis to support quanti-
tative, but not qualitative, spermatogenesis is perturbed at
these ages. However, this is not reﬂected in circulating
follicle-stimulating hormone (FSH) concentration, which
remains unchanged between control and LCARKOs when
examined at d 80 (Fig. 3G). The reduction in germ cell
maturation is apparent upon examination of the
Figure 2. LCARKO mice have reduced testis size and weight.
The mean weight of LCARKO testes is comparable with
controls at d 21 (14.49 mg control; 14.21 mg LCARKO) and
d 35 (40.62 mg control; 32.32 mg LCARKO). At d 80, the
LCARKO mean testis weight is signiﬁcantly reduced com-
pared to controls (71.19 mg control; 56.28 mg LCARKO; *P,
0.05), and testes are visibly smaller (photo inset; scale bar
increments of 1 mm). At 6 mo (6m) old, the mean LCARKO
testes weight is also reduced compared to controls (98.08 mg
control; 72.29 mg LCARKO; ****P , 0.0001). Error bars, SEM.
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epididymis.Mature spermatozoa canbe seen in the lumen
of the control cauda epididymis at d 80. In age-matched
LCARKOs, a visible increase in the number of immature
germ cells sloughed prematurely from the seminiferous
epithelium is evident (Fig. 3H, arrows). Mature caudal
spermatozoa are also present in 19-mo-old controls, but
a visible reduction in the number of spermatozoa is ap-
parent in age-matched LCARKO mice (Fig. 3I).
Figure 3. LCARKOmicehavedegenerative testicularhistology.A)Testicularhistology is similarbetweenLCARKOsandcontrolsatd21.
B)Testicularhistology is similarbetweenLCARKOsandcontrolsatd35.C)Atd80,LCARKOtestes showfociof seminiferousepithelium
degeneration (asterisk), whereas controls still appearnormal.D)At6moof age, foci of seminiferousepitheliumdegenerationaremore
widespread in theLCARKO(asterisks),whichalsohave largepink/orange-stainingmultinucleatecells in the interstitium(arrow).
Testes from controls are unaffected. E) LCARKOs have a reduction in testicular spermatocyte volume at d 35 (5.4 mg control; 3.0 mg
LCARKO;*P,0.05)andd80 (6.3mgcontrol; 4.2mgLCARKO)compared to controls. Errorbars, SEM.F)LCARKOshave a reduction in
testicular spermatid volume compared to controls at d 35 (2.6mg control; 1.5mgLCARKO) and d 80 (8.3mg control; 5.5mgLCARKO;
**P,0.01).Errorbars,SEM.G)FSHlevelsarenormalinLCARKOcomparedtocontrolsatd80andforhCGtreatedatd100.Errorbars,SEM.
H)Spermatozoaarepresent in thecaudaepididymisofbothcontrols andLCARKOsatd80,but immature roundsloughedgermcells are
also seen in theLCARKO(arrows). I)Fewer spermatozoaarepresent in thecaudaofLCARKOs thancontrols at 19mo. Scalebars, 50mm.
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Similar to many Cre recombinase lines, Fabp4-Cre is
expressed at varying levels in different tissues in the body
(49) but has been primarily used to ablate AR in the CNS
(50) and adipocytes (25), so it was necessary to rule out the
possibility that the observed testicular phenotype resulted
secondarily from the loss of AR in these tissues. Both an-
drogen receptor knockout (ARKO) and brain-speciﬁc
ARKO mice display changes in mating behavior (51);
however, analysis of mating behavior in LCARKO mice
identiﬁed no signiﬁcant difference in the number of suc-
cessful matings compared to controls (data not shown),
demonstrating that any targeting of AR in the brain using
Fabp4-Crehasminimalphenotypic impact.To ruleout any
inﬂuence due to the loss of AR from adipocytes, we
exploited a second adipocyte-speciﬁc Cre recombinase
line [adiponectin-Cre (Adipoq-Cre) (37)] to generate an
adipocyte androgen receptor knockout (Adipo-ARKO)
mouse. Although this line efﬁciently ablates AR from adi-
pocytes, it did not ablate AR from any cells of the testis
(Supplemental Fig. S1B). The resulting Adipo-ARKO
mouse displays no testicular phenotype (Supplemental
Fig. S1C), and gene expression of steroidogenic enzymes
and Leydig cell maturation markers are unchanged (Sup-
plemental Fig. S1D). We therefore concluded that the
progressive testicular degeneration seen in LCARKOmice
(Fig. 3) results directly from speciﬁc AR ablation from the
adult Leydig cell population.
Leydig cell AR signaling does not control ﬁnal adult
Leydig cell number
Having determined that the loss of Leydig cell AR induces
a progressive degenerative phenotype in the testis, we next
aimed to establish the speciﬁc role of AR in developing
adult Leydig cells. Previously published literature states
that AR functions in adult Leydig cells to determine ﬁnal
Leydig cell number (19). We quantiﬁed the number of
Leydig cells at d 21, 35, and 80, by which age adult Leydig
cells have fully matured and reached their ﬁnal number.
Surprisingly, Leydig cell number is not signiﬁcantly dif-
ferent between control and LCARKOat any age examined
(Fig. 4A). Thus, in contrast to the published literature,
these data suggest that autocrine AR action is not required
within adult Leydig cells for the attainment of ﬁnal adult
Leydig cell number.
Leydig cell AR signaling controls adult Leydig
cell maturation
In addition to controlling Leydig cell number, AR in adult
Leydig cells has been postulated to control adult Leydig
cell maturation (19, 22). Ablation of AR from adult Leydig
cells is associatedwith adult Leydig cell hypertrophy at d 80
(Fig. 4B) Leydig cell cytoplasm is increased in size, remi-
niscent of immature adult Leydig cells (Fig. 4C) (52).
Consistent with this, expression of 3 genes previously
demonstrated to be restricted to mature adult Leydig
cells (Hsd3b6, Ptgds, and Insl3) is signiﬁcantly re-
duced in LCARKO testes when examined at d 80,
suggesting a failure of adult Leydig cell maturation (Fig.
4D–F). These gene expression data are further supported
by immunohistochemical localization of the Leydig cell
maturation marker INSL3, which is present in all Leydig
cells of control testes but is restricted to a subset of Leydig
cells withinLCARKOtestes (Fig. 4G).Together, thesedata
strongly support the previously postulated role for Leydig
cell AR in promoting adult Leydig cell maturation.
Leydig cell AR signaling controls steroidogenesis
Previous data from the Tfm (ARKO) mouse model de-
scribe signiﬁcant changes in expression levels and activity
of steroidogenic enzymes, which have been attributed to
the loss of AR in adult Leydig cells (19, 20, 22). To establish
whether this is indeed a direct effect of the loss of AR
signaling speciﬁcally from adult Leydig cells, we compared
transcript and protein levels of these steroidogenic
enzymes between LCARKO and complete-ARKO mice
at d 80. mRNA expression of Cyp17a1 is signiﬁcantly re-
duced in LCARKO testes and is completely absent from
ARKO testes, suggesting that Leydig cell AR inﬂuences
expression of this enzyme (Fig. 5A). However, double-
immunoﬂuorescence localization of AR and CYP17A1
in d 80 LCARKO testes reveals no obvious spatial correla-
tion between the loss of AR and altered expression of
CYP17A1 (Fig. 5B), suggesting that, whereas Leydig cell AR
may inﬂuence gene expression, the complete absence of
Cyp17a1 expression observed in the ARKO model is not
due to the loss of AR expression speciﬁcally from adult
Leydig cells. In contrast, whereas Hsd17b3 expression is
also signiﬁcantly reduced in LCARKO testes (Fig. 5C),
immunohistochemistry forHSD17B3 in80-d-oldLCARKO
testes (Fig. 5D) revealed that there are both HSD17B3-
positive and HSD17B3-negative cell populations with
Leydig cell morphology in the LCARKO testis. Double-
immunoﬂuorescence localization of AR and HSD17B3 in
80-d-old LCARKO testes (Fig. 5E) conﬁrmed that whereas
AR-positive Leydig cells in both controls and LCARKOs
express HSD17B3, AR-negative Leydig cells in the
LCARKO do not, suggesting that HSD17B3 protein ex-
pression is dependent on autocrine AR action within
Leydig cells. Surprisingly, whereas transcript levels of
Hsd3b1 and Cyp11a1 do not differ between ARKO and
control testes, both are signiﬁcantly increased inLCARKO
testes (Fig. 5F andG), suggesting that androgens normally
act to attenuate gene expression of these enzyme tran-
scripts. Toexaminewhether increasedexpression of these
2 transcripts was functionally signiﬁcant, we determined
intratesticular progesterone concentrations, which would
be enhanced by increased CYP11A1 and HSD3B1 activi-
ties. Indeed, a signiﬁcant increase in intratesticular pro-
gesterone was detected at d 80 (Fig. 5H), consistent with
this hypothesis. Together, these data suggest that auto-
crine AR action is required to positively and negatively
regulate expression (and by doing so, activity) of key
enzymes, in support of normal steroidogenesis.
Seminiferous tubule degeneration in LCARKOs is
independent of T concentration
Having characterized the role that adult Leydig cell AR
plays in adult Leydig cell development and function, we
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moved to establish the cause of the degenerative testicular
phenotype observed in LCARKO mice. A rat model of
Leydig cell ablation by ethane dimethane sulfonate (EDS)
and supplementation with T has shown that T is necessary
and sufﬁcient to support spermatogenesis (53). By in-
ference, this suggests that the only product produced by
Leydig cells necessary for spermatogenesis is T. Given the
impact that Leydig cell AR loss has on adult Leydig cell
maturation and steroidogenic enzyme expression, in-
cluding loss of HSD17B3 protein from many Leydig cells,
we hypothesized that the seminiferous tubule degen-
eration observed in the LCARKOmouse results from a re-
duction in adult Leydig cell T production. However, no
signiﬁcant difference in circulating T is observed between
LCARKO and control mice when examined at d 80 (when
seminiferous tubule degeneration is already apparent), or
when control and LCARKOmice are injected with a high-
dose hCG stimulus at d 100 or at 7–12 mo of age (Fig. 5I).
Moreover, blood levels of LH are unchanged from control
values at d80 (Fig. 5J). Intratesticular testosterone (ITT)was
also measured and found to be unchanged in LCARKOs
compared to controls at d 80 (Fig. 5K). Together, these
data suggest that androgen production by adult Leydig
cells not only promotes spermatogenesis but also acts via
Leydig cell AR to prevent seminiferous tubule de-
generation, perhaps by suppressing aberrant production
of another factor by adult Leydig cells, which is detri-
mental to spermatogenesis. Themost obvious candidate
for this factor is the increase in progesterone pro-
duction, and the possibility for increased progesterone
signaling; however, expression of Pgr was undetectable
in the testis at d 80 (data not shown), effectively ruling
this out.
Loss of AR leads to late-onset Leydig cell apoptosis in
LCARKO mice and patients with CAIS
To examine seminiferous tubule degradation in further
detail, additional histologic inspection of LCARKO testes
was undertaken. As a reduction in the second major adult
Leydig cell product, INSL3 had been identiﬁed and that
RXFPL, the receptor for INSL3, is expressed in germ cells
(54), we hypothesized that impaired INSL3 signaling may
result in germ cell apoptosis, which would explain the tu-
bular degeneration. However, there is no visible difference
in the number of apoptotic germ cells between the testes of
LCARKOs and controls at d 21, 35, and 80 (Fig. 6A–D), in
agreement with a recent study suggesting that INSL3 is
dispensable for spermatogenesis (55). However, surpris-
ingly, given that the Leydig cell population normally dis-
plays minimal cell turnover (56), Leydig cell apoptosis is
evident in the interstitium of the LCARKO testis at
both d 80 and 100 and also at 6–9 mo of age (Fig. 6C, D).
Staining at d 80–100 is punctate and in the cytoplasm of
cells (Fig. 6C, arrows). By 6–9mo, this punctate staining can
still be seen (Fig. 6D, arrows), but large, completely stained
cells can also be seen at this later age. Both of these staining
patterns are classiﬁed as positive and quantiﬁed as 31%
Leydig cells staining positive for cleavedCASP3 at d 80–100
Figure 4. LCARKO Leydig cells reach ﬁnal adult number but do not express mature Leydig cell markers. A) The total number of
Leydig cells per testis is not signiﬁcantly different between controls and LCARKOs at d 21, 35, and 80. Error bars, SEM. B) The
percentage of testis occupied by Leydig cells (staining for HSD3B) appears to be larger in the LCARKO than in the control. Scale
bars, 100 mm. C) The size of Leydig cell cytoplasm appears larger in LCARKOs than controls at d 80 (lines delineate seminiferous
tubules in control panel; arrows indicate interstitium). Scale bars, 20 mm. D) Hsd3b6 is signiﬁcantly decreased (****P , 0.0001) in
LCARKO testis compared to controls at d 80 and is absent in ARKO testis. E) Ptgds is signiﬁcantly decreased (****P , 0.0001)
in LCARKO testis compared to controls at d 80 and is absent in ARKO testis. F) Insl3 is signiﬁcantly decreased (****P , 0.0001) in
LCARKO testis compared to controls at d 80 and is absent in ARKO testis. G) INSL3 staining is widespread throughout the
interstitium of control testes, but LCARKO testes show 2 populations of cells with Leydig cell-like morphology: a larger population
that does not stain for INSL3 (arrowhead); and a smaller population that does (arrows). Scale bars, 20 mm.
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and 51% at 6–9 mo (Fig. 6E). No Leydig cell apoptosis is
noted in the interstitium of age-matched controls.
We hypothesized that the Leydig cell apoptosis could
result from chronic hyperstimulation of Leydig cell ste-
roidogenesis, which is known to increase cellular stress (57)
in the ;25% of Leydig cells retaining AR expression.
These cells may be required to increase their T production
to maintain circulating levels as a compensation for the
poorly functioning AR knockout (KO) Leydig cells. How-
ever,hCG-mediated interrogationofmaximalTproduction
at either d 100 or 7–12 mo (Fig. 5H) reveals no signiﬁcant
difference between LCARKO and control animals, sug-
gesting that Leydig cell production of T is unaffected by
the loss of AR, and by inference, that the remaining
AR-positive Leydig cells are not under obvious stress. In fact,
contrary to this, double immunolocalization of CASP3 and
AR shows that apoptosis was only observed in Leydig cells
lacking AR expression. Adjacent Leydig cells retaining AR
are unaffected (Fig. 6F). This is suggestive of a failure of an
unknown AR-dependent autocrine function, which marks
AR-negative Leydig cells for apoptosis. In contrast to the
LCARKO mouse, Leydig cells in total-ARKO mice did not
show signs of apoptosis at d 80 or 9 mo (Fig. 6G,H).
TheLCARKOmousemodel with its normal T levels and
lack of functioning AR is reminiscent of CAIS in humans
(normal/high T; no AR), unlike the Tfm or ARKOmouse,
which has low T levels and absent steroidogenesis, and
because we have recently identiﬁed that adult Leydig cells
Figure 5. LCARKO testes have changes in steroidogenic enzyme expression but produce normal levels of T. A) Cyp17a1 gene
expression is signiﬁcantly decreased (****P , 0.0001) in LCARKO testis compared to controls at d 80 and is absent in ARKO
testis. B) AR immunostaining (green) is seen in the nuclei of CYP17A1 (blue)-positive Leydig cells in controls (arrowhead). Both
AR-positive (arrowhead) and -negative (arrow) cells in LCARKOs express CYP17A1. Scale bars, 20 mm. C) Hsd17b3 gene
expression is signiﬁcantly decreased (**P, 0.01) in LCARKO testis compared to controls at d 80 and is absent in ARKO testis. D)
Two populations of Leydig cells can be seen in the LCARKO: an HSD17B3-positive population (arrowheads), and an HSD17B3-
negative population (arrow). Scale bars, 20 mm E) AR immunostaining (red) is seen in the nuclei of HSD17B3 (blue)-positive
Leydig cells in controls. In LCARKOs, HSD17B3 is localized to AR-positive cells (arrowhead), but not AR-negative cells (arrow).
Scale bars, 20 mm. F) Hsbd3b1 gene expression is signiﬁcantly increased (**P , 0.01) in LCARKO testis compared to controls at
d 80. G) Cyp11a1 gene expression is signiﬁcantly increased (***P , 0.001) in LCARKO testis compared to controls at d 80. H)
Intratesticular progesterone is signiﬁcantly increased (**P , 0.01) in LCARKO compared to control mice at d 80. I) Plasma T
levels are not signiﬁcantly different between control and LCARKO mice at d 80, d 100 hCG treated, and 7–12 mo hCG treated. J )
Plasma LH levels are not signiﬁcantly different between control and LCARKO mice at d 80. K) ITT levels are not signiﬁcantly
different between control and LCARKO testes at d 80.
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arise from the same stem cell population in bothmice and
humans (16), we assayed for apoptosis in testicular biopsies
of patients with CAIS at different ages. Apoptosis is not
detectable in younger patients aged 6 (Fig. 6I) or 15 (Fig.
6J) yr withCAIS, but patients aged 20 (Fig. 6K) and 36 (Fig.
6L) yr both show extensive interstitial cell apoptosis in cells
with extensive cytoplasm that can be identiﬁed morpho-
logically as Leydig cells. Biopsies from normal adult testes
do not show Leydig cell apoptosis (Fig. 6L, inset).
Increase in ESR1 signaling in LCARKO testis
In addition to the evidence of Leydig cell apoptosis,
phagocytic macrophages were noted in the testicular
interstitium of adult LCARKO testes (Fig. 7A, arrow). Two
other mouse models described in the literature display
a similar phenotype of progressive seminiferous tubule
degeneration, both of which are associated with a chronic
increase in estrogen signaling within the testis, either
through over-expression of Arom (58) or KO of estrogen
sulfotransferase (SULT1E1) (59). To assess the possibility
that increased estrogen signaling is a mechanism un-
derpinning our observations, we interrogated key
components of the estrogen signaling system. We ob-
served no signiﬁcant difference in concentrations of ei-
ther intratesticular or plasma estradiol between LCARKO
and control animals (Fig. 7B, C), and the concentrations
of Cyp19a1 transcript (Fig. 7D) and CYP19A1 protein
(Fig. 7E) are both unchanged in LCARKO testes com-
pared to the control. Seminal vesicle weight is signiﬁcantly
increased in the LCARKOmodel, similar to that observed
in the SULT1E1-KO(Fig. 7F); however, surprisingly, levels
of the Sult1e1 transcript are slightly increased (Fig. 7G).
We localized ESR1 (ERa) protein by immunohisto-
chemistry using an antibody raised against the C-terminal
of the mouse protein and found it to be present in the
Leydig, PTM, and Sertoli cells of the testis in both control
andLCARKOmice (Fig. 7H). A signiﬁcant increase in Esr1
transcript (Fig. 7I) and in the 46 kDa isoform of ESR1
protein (Fig. 7J) is noted in LCARKOcompared to control
testes. A signiﬁcant increase in transcription of Gas6,
a downstream target of ESR1 signaling in Leydig cells (60)
(Fig. 7K), is also observed in the LCARKO testes, suggest-
ing that the phenotypic changes associated with estrogen
in the LCARKO may result from an increase in ESR1 sig-
naling rather than an increased level of estradiol.
Figure 6. Apoptosis is seen in both aged LCARKOs and CAIS patient biopsies. A and B) No interstitial apoptosis (marked by
CASP3 immunostaining) was observed in the interstitium of d 21, or d 35 control or LCARKO testes. A few germ cells were noted
to stain for CASP3 in each section. C) No interstitial CASP3 immunostaining was observed in the interstitium of d 80 control
mice. Punctate CASP3 immunostaining was observed in cells with Leydig cell morphology in d 80 LCARKO mice (arrows). D)
Extensive interstitial apoptosis was noted in the interstitium of 6- to 9-mo-old LCARKO testes, unlike age-matched controls. E)
When quantiﬁed, 31% of Leydig cells at d 80–100 and 51% of cells at 6–9 mo were found to immunostain positive for CASP3. F)
CASP staining (blue) was noted in AR (brown)-negative cells (arrows), and not AR-positive cells.. G and H) No interstitial apoptosis
was noted in either d 80 or aged ARKO mice. I and J) No apoptosis was noted in biopsies from 6- or 15-yr-old patients with CAIS. K
and L) Extensive interstitial apoptosis was noted in biopsies from 20- and 36-yr-old patients with CAIS, whereas biopsies from normal
adult men (inset) did not show apoptosis. Scale bars, 50 mm.
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Figure 7. LCARKO testes show an increase in ESR1 signaling. A) Multinucleate cells that stain pink/orange with hematoxylin and
eosin are noted in $6-mo-old LCARKO testis interstitium (arrow). Scale bar, 50 mm. B) Intratesticular estradiol levels are not
signiﬁcantly different between control and LCARKO mice at d 80. C) Plasma estradiol levels are not signiﬁcantly different
between control and LCARKOmice at d 80 or for hCG treated at d 100. D) Cyp19a1 is not signiﬁcantly different in LCARKO testis
compared to controls at d 80. E) Levels of CYP19A1 (green; 58 kDa) normalized to GAPDH (red; 37 kDa) are not signiﬁcantly
different between LCARKO and controls at d 100. Error bars, SEM. F ) Seminal vesicles are visibly larger (arrows) and also
signiﬁcantly heavier (***P , 0.001) in LCARKO compared to control mice post 6 mo of age. G) Sult1e1 gene expression is
signiﬁcantly increased (*P , 0.05) in LCARKO testis compared to controls at d 80. H) ESR1 (green) is localized to Sertoli, PTM,
and Leydig cell nuclei in both control and LCARKO testis. Scale bars, 50 mm. I) Esr1 gene expression is signiﬁcantly increased
(**P, 0.01) in LCARKO testis compared to controls at d 80. J) Levels of the 46 kDa isoform of ESR1 (red) normalized to a-tubulin
(red; 55 kDa) are signiﬁcantly increased in LCARKO testes compared to controls at d 100 (P , 0.05), but the levels of the 66 kDa
isoform are not signiﬁcantly different. K) Gas6 gene expression is signiﬁcantly increased (**P , 0.01) in LCARKO testis compared
to controls at d 80.
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DISCUSSION
To examine the role of androgen action within de-
veloping Leydig cells, we generated a novel mouse
model lacking testicular AR speciﬁcally in the adult
Leydig cell population, from the stem cell stage
(17.5 d postconception) onward. Because 25% of Leydig
cells retain AR, this model provides a unique opportu-
nity to determine the roles of autocrine AR signaling
within Leydig cells in vivo because it permits the com-
parison of adjacent Leydig cells, all exposed to the same
endocrine and paracrine environment, with one differ-
ence: retention or absence of Leydig cell AR. We show
that autocrine androgen action within developing
adult Leydig cells is dispensable for the attainment
of ﬁnal Leydig cell numbers in adulthood but is es-
sential for correct Leydig cell maturation and normal
steroidogenic enzyme transcription. Although these
defects do not initially impact testis function either in
terms of spermatogenesis or T production, we show for
the ﬁrst time that failure of autocrine androgen action
in developing Leydig cells eventually leads to seminif-
erous tubule degeneration in mice, and increased
Leydig cell apoptosis in adulthood, possibly via a failure
to oppose testicular estrogen signaling. Because a sim-
ilar increase in Leydig cell apoptosis was observed in
adult human patients with CAIS, in whom Leydig cell
AR function is also absent, our ﬁndings may have rel-
evance to humans.
Autocrine AR signaling is dispensable for the
attainment of normal Leydig cell numbers
Leydig cell number in the Tfm is 60% of controls (19),
demonstrating that androgen signaling is essential for the
attainment of ﬁnal Leydig cell number. However, Leydig
cell number in the LCARKO testis at d 21 and 35 and in
adulthood at d 80 (before the onset of the degenerative
phenotype) does not differ from control littermates. Fur-
thermore, the proportion of AR-positive and AR-negative
Leydig cells remains constant between d 21 and 35 (a time
of intense Leydig cell proliferation), consistent with no
difference in proliferation rate in Leydig cells that lack AR.
Together, these data show that the loss of autocrine AR
signaling within Leydig cells does not inhibit their pro-
liferation or the attainment of ﬁnal numbers. This suggests
that the reduction inLeydig cells observed in theTfm is due
to the absence of androgen signaling in another cell type(s).
Recent data from our group have demonstrated that Sertoli
cells arekeydriversofﬁnalLeydigcellnumbers inadulthood
(61), which is consistent with previous evidence sug-
gesting that AR signaling within Sertoli cells may be the
mechanism by which androgen signaling controls Leydig
cell numbers (52, 62).
Autocrine AR signaling is essential for Leydig cell
maturation and normal steroidogenic
enzyme transcription
Several lines of evidence arising from theTfm studies point
to the importance of Leydig cell AR signaling in the mat-
uration of Leydig cells to the adult Leydig cell stage,
including the absence of expression of the maturation
markers Insl3, Hsd3b6, and Ptgds (19), retention of imma-
ture adult Leydig cell morphology, and a reduction in
smooth endoplasmic reticulum normally associated with
immature adult Leydig cells (22). Like theTfm,maturation
appears to be compromised in LCARKOLeydig cells. Loss
of endogenous AR expression leads to a reduction in the
adult Leydig cell-speciﬁc transcripts Ptgds, Cyp17a1,
Hsd17b3, andHsd3b6, aswell as INSL3atboth the transcript
and protein level. Conversely, whereas also absent in the
Tfm testes, expression of the earlier-onset steroidogenic
enzymes Hsd3b1 and Cyp11a1 is signiﬁcantly increased in
LCARKO testes compared to controls at d 80, leading to an
increase in intratesticular progesterone. The reason for
this is unclear, but this may reﬂect a compensatory mech-
anism for the loss of AR, a release from normal AR-
mediated control, or a reﬂection of the arrested stage.
Indeed, regulation of the genes Hsd3b6, Ptgds, Insl3,
Hsd17b3, and Cyp11a1 in response to androgen stimula-
tion has been reported in a number ofmouse or rat tissues
and in transcriptomic studies in both rodent and human
tissue and cells [identiﬁed via (63, 64)]. Despite the data
summarized above, there is a paucity of information re-
garding the identiﬁcation of sequences mediating AR
bindingand transcriptional regulation for theabovegenes.
A notable exception is the Insl3 genes, where a region
mediating androgen regulation has been mapped to
sequences in the promoter,2132 to285 (65). An empir-
ical analysis of the genomic sequence 59 and39of the genes
Hsd3b1, Hsd17b3, and Cyp11a1, as well as coding se-
quences, identiﬁes a number of putative palindromic
binding sites for the AR, with .80% identity with the
consensus receptor binding sequence, together with
a large number of half-sites matching the sequence
AGAACA/T. The presence of these binding sites would be
consistent with direct regulation of these genes by the AR
(Supplemental Fig. S3). Importantly, modulation of these
enzymes leading to the increased local availability of pro-
gesterone as a substrate for T production by adjacent
HSD17B3-expressing Leydig cells may in part explain why
T levels both within the testis and in the circulation are
unchanged relative to controls, without modulation of
circulating LH levels. A similar paradigm of intercellular
steroidogenesis is apparent in the fetal testis, where ste-
roid precursors produced by the fetal Leydig cells un-
dergo ﬁnal conversion to T by HSD17B3 within the
Sertoli cells (66, 67).
In addition to transcriptional changes, Leydig cells
lacking AR retain the hyperplastic phenotype seen in
the Tfm, indicative of an arrest at the immature adult
Leydig cell stage. This arrest is similar to that observed in
Leydig cells in a previous PTM ARKO (68). Recent data
demonstrating that Leydig cells can develop from
ACTA2-expressing PTM cells (69) perhaps explain this
observation, identifying PTM cells as a potential source
of Leydig stem cells in the adult testis. In conclusion,
Leydig cell maturation and steroidogenic enzyme ex-
pression would appear to be key roles of autocrine AR
signaling within Leydig cells because adjacent cells
retaining AR expression mature normally (determined
both by histology and maturation marker expression,
e.g., INSL3) but cannot promote maturation in adjacent
AR-negative Leydig cells.
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Autocrine AR signaling in Leydig cells protects against
late-onset disruption to spermatogenesis
As discussed above, despite the failure of the majority of
Leydig cells to fully mature and the changes in steroido-
genic enzyme transcription, circulatingplasmaT, ITT, and
LH levels are all unchanged in LCARKO mice. This is in
contrast to theTfm in which serumT levels are signiﬁcantly
decreased despite high levels of LH (20, 21). In line with
this normal hormonal proﬁle, spermatogenesis proceeds
normally, and LCARKOmice are fertile at d 80. However,
from d 80 onward, the LCARKO exhibits a phenotype of
focal germ cell loss that becomes increasingly more wide-
spread with age. This could in part be due to a paracrine
effect of Leydig cells on PTM cells because DES protein
localization is disrupted in the LCARKO testis. However,
this inﬂuence is likely to be minimal because other PTM
markers are normal, and spermatogenesis develops nor-
mally, in contrast to the PTM-ARKO mouse, which shows
defects in spermatogenesis from d 15 (30).
The Leydig cells make 2 major products: INSL3 and T.
INSL3 is almost absent at the transcript level and absent
from a majority of Leydig cells at the protein level in the
LCARKO. There is some evidence that INSL3 protects
against germ cell loss/apoptosis (54, 70, 71); however, re-
centdata fromagermcell-speciﬁcKOofRxfp2 showed that
INSL3 signaling is dispensable for spermatogenesis (55).
In contrast, T replacement is able to completely rescue
spermatogenesis following EDS-mediated Leydig cell ab-
lation in rats (53). This suggests that the only product
produced by Leydig cells, necessary and sufﬁcient for
spermatogenesis, is T. However, the LCARKO testis
exhibits germ cell loss despite normal ITT levels. The only
major difference between the EDS rat model and the
LCARKO is that Leydig cells are retained in the LCARKO
model, suggesting that the loss of Leydig cell AR results in
production of a factor(s) toxic to spermatogenesis. One
candidate for this factor would be progesterone, which is
signiﬁcantly increased in the LCARKO testis. However, we
were unable to detect any gene expression of Pgr in the
testis at d 80, suggesting that direct action by progesterone
does not underpin this phenotype.
Autocrine AR signaling in Leydig cells protects against
Leydig cell apoptosis
In addition to impacting spermatogenesis, the absence
of autocrine AR signaling is associated with premature
Leydig cell apoptosis, whereas adjacentAR-positiveLeydig
cells remain unaffected. Because the onset of Leydig cell
apoptosis occurs after the onset of germ cell loss, it is
likely that both are separate manifestations of the same
underlying dysregulation of Leydig cells in the LCARKO
model, possibly acting via different pathways, rather than
the germ cell loss being somehow directly linked to
Leydig cell apoptosis. We cannot rule out the possibility
that germ cell loss induces Leydig cell apoptosis, although
this appears unlikely because this is not seen in models
of germ cell ablation using either busulphan (72, 73) or
diphtheria toxin (61), and also would not explain why
LC apoptosis is restricted to LCs that lack endogenous
AR expression.
Leydig cell apoptosis is not normally observed in the
mouse (56), and in the context of thedata discussed above,
themost likely scenario in LCARKOmice is that the loss of
autocrine AR signaling results in production of something
toxic toLeydig cell survival. Oxidative damage is associated
with Leydig cell apoptosis in vitro (74), and it would appear
possible that failure to complete maturation would lead to
aberrant steroidogenesis, possibly increasing free radical
damage. However, acute hCG-mediated stimulation of
maximal T output identiﬁed no signiﬁcant difference in T
production capacity between LCARKO and control testes
at eitherd 80 or;8moof age.Because current hypotheses
suggest that oxidative stressdamageresults in adecline inT
production (75), this implies that, despite the attractive-
ness of this argument, oxidative stress is not a major factor
in driving increased Leydig cell apoptosis.
Loss of Leydig cell AR phenocopies models of
increased estrogen signaling
Androgen/estrogen balance is important for health, and
there is evidence that it is involved in the etiology of obesity
(76), cardiovascular disease (77), and benign prostatic
hyperplasia (76, 78) as well as infertility. The phenotype of
germ cell loss and Leydig cell apoptosis associated with
interstitial macrophage phagocytosis observed in the
LCARKO testis is similar to 2 mouse models in the litera-
ture that have an excess of estrogen signaling in the testis.
One is a model with an overexpression of CYP19A1
(Arom), the enzyme responsible for converting androgens
into estrogens (58); the other is a global genetic KO of
SULT1E1, an enzyme that inactivates estrogens by sulfa-
tion (59). We observed no increase in CYP19A1 at either
the transcript or protein level in the LCARKO testis, and
concentrations of plasma and intratesticular estradiol were
normal in the LCARKO model, demonstrating that, al-
though thephenotypesare similarbetween theArom+and
LCARKO models, the underlying mechanism differs be-
cause AR does not control CYP19A1 expression in Leydig
cells. Sult1e1 shows discrete and highly regulated expres-
sion restricted to the placenta, liver, epididymis,
and testicular Leydig cells (79–81) and is positively
transcriptionally regulated by androgens (82). In contrast
to this previous study, we observed a small increase in
Sult1e1 transcript in the LCARKO testis, although the lack
of availability of a functioning antibody prevented quanti-
ﬁcation or spatial localization at the protein level. As such,
we cannot rule out the possibly that this small increase in
detectable Sult1e1 transcript arises from Leydig cells that
retain AR expression. However, the signiﬁcant increase in
seminal vesicle weight observed in the LCARKO mouse is
also seen in the SULT1E1-KOmouse, where it is attributed
to increased availability of nonsulfated estrogen, suggest-
ing that modulation of SULT1E1 function in Leydig cells
could play a role in the observedLCARKOphenotype; this
requires further investigation. Additional evidence sup-
porting increased local estrogen signaling is provided by
the observation of an up-regulation in estrogen signaling
pathways through ESR1: Esr1 is up-regulated at the tran-
script level, and the 46 kDa isoform of ESR1 (83) is sig-
niﬁcantly increased at the protein level, whereas Gas6
[an established downstream ESR1 signaling target within
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Leydig cells (60)] also shows signiﬁcantly increased tran-
scription. Similar up-regulation of ESR1 is seen in AR-
ablated cells in other conditional ARKO models (27, 84,
85), suggesting that AR may act to repress aberrant ex-
pression of ESR1 in some cell types, probably via an in-
termediary factor. Finally, consistent with this conclusion,
patients with CAIS show a well-documented signiﬁcant
increase in estrogen production at puberty (86), which
closely follows the ontogeny of Leydig cell apoptosis in
CAIS testes observed in this study. This suggests that the
loss of Leydig cell AR signaling results in failure to op-
pose local estrogen signaling, leading to late-onset testic-
ular degeneration and Leydig cell apoptosis in both mice
and humans.
Although amodel of increased estrogen signaling in the
LCARKO is extremely attractive, especially in light of a re-
cently published follow-up study investigating the mecha-
nism of Leydig cell apoptosis in the Arom+ mouse, which
shares many of the features we observe in the LCARKO
(60), we are unable to rule out the possibility that the
similar phenotypes of the Arom+, SULT1E1-KO, and the
LCARKO models all reﬂect a general response to pertur-
bation of Leydig cell maturation and adult Leydig cell
function. It is clear that elucidating these mechanisms
requires signiﬁcant further investigation. Furthermore,
whereas we clearly demonstrate several key roles for
autocrine androgen action with Leydig cells, we cannot
rule out additional roles for Leydig cell AR signaling that
may be revealed through ablation of AR action from all
Leydig cells.
Nevertheless, in conclusion, these analyses identify im-
portant and hitherto unknown autocrine roles for an-
drogen signaling in Leydig cell maturation and testis
function. Our identiﬁcation that perturbed androgen ac-
tion in the developingLeydig cell lineage leads to a failure
of Leydig cell maturation and perturbed function, asso-
ciated with late-onset degeneration of spermatogenesis in
mice and Leydig cell apoptosis in both mice and humans,
is an important ﬁnding that may have implications for
men during aging.
The authors thank Lyndsey Cruickshanks, Nathan Jeffery,
Mike Dodds, Mike Millar, Nancy Evans, Ruth Hamblin, and
Dr. Forbes Howie for technical support, Dr. Karel De Gendt
and Professor Guido Verhoeven for provision of the ARﬂox
mouse line, and Professors Iain J. McEwan and Richard Sharpe
for comments on the manuscript. L.O., R.T.M., and L.B.S.
conceived and designed the study. L.O., K.M., L.M., I.S., S.M.,
and N.A. carried out experiments. L.O., R.T.M., and L.B.S.
analyzed the results. J.S.-H., K.K., M.S.-C., and R.T.M. provided
novel resources. L.O. and L.B.S. wrote the paper. This work was
funded by Medical Research Council Program Grant Award
G1100354/1 (to L.B.S.); Wellcome Trust Intermediate Clinical
Fellowship (Grant 098522) (to R.T.M.); and Polish Ministry of
Science Award (Grant N N407 277339) (to J.S.-H.).
REFERENCES
1. Yeap, B. B. (2010) Androgens and cardiovascular disease. Curr.
Opin. Endocrinol. Diabetes Obes. 17, 269–276
2. Farrell, J. B., Deshmukh, A., and Baghaie, A. A. (2008) Low
testosterone and the association with type 2 diabetes. Diabetes
Educ. 34, 799–806
3. Kupelian, V., Hayes, F. J., Link, C. L., Rosen, R., and McKinlay,
J. B. (2008) Inverse association of testosterone and the metabolic
syndrome in men is consistent across race and ethnic groups.
J. Clin. Endocrinol. Metab. 93, 3403–3410
4. Kupelian, V., Page, S. T., Araujo, A. B., Travison, T. G., Bremner,
W. J., and McKinlay, J. B. (2006) Low sex hormone-binding
globulin, total testosterone, and symptomatic androgen de-
ﬁciency are associated with development of the metabolic syn-
drome in nonobese men. J. Clin. Endocrinol. Metab. 91, 843–850
5. Saad, F., and Gooren, L. (2009) The role of testosterone in the
metabolic syndrome: a review. J. Steroid Biochem. Mol. Biol. 114,
40–43
6. Laughlin, G. A., Barrett-Connor, E., and Bergstrom, J. (2008)
Low serum testosterone and mortality in older men. J. Clin.
Endocrinol. Metab. 93, 68–75
7. Pye, S. R., Huhtaniemi, I. T., Finn, J. D., Lee, D. M., O’Neill,
T. W., Tajar, A., Bartfai, G., Boonen, S., Casanueva, F. F., Forti,
G., Giwercman, A., Han, T. S., Kula, K., Lean, M. E., Pendleton,
N., Punab, M., Rutter, M. K., Vanderschueren, D., and Wu, F. C.,
E.M.A.S. Study Group (2014) Late-onset hypogonadism and
mortality in aging men. J. Clin. Endocrinol. Metab. 99, 1357–1366
8. Ge, R. S., Shan, L. X., and Hardy, M. P. (1996) Pubertal de-
velopment of Leydig cells. In The Leydig Cell (Payne, A. H., Hardy,
M. P., and Russell, L. D., eds.), pp. 159–174, Cache River Press,
Vienna, Austria
9. Neaves, W. B., Johnson, L., Porter, J. C., Parker, C. R., Jr., and
Petty, C. S. (1984) Leydig cell numbers, daily sperm production,
and serum gonadotropin levels in aging men. J. Clin. Endocrinol.
Metab. 59, 756–763
10. Neaves, W. B., Johnson, L., and Petty, C. S. (1985) Age-related
change in numbers of other interstitial cells in testes of adult
men: evidence bearing on the fate of Leydig cells lost with in-
creasing age. Biol. Reprod. 33, 259–269
11. Midzak, A. S., Chen, H., Papadopoulos, V., and Zirkin, B. R.
(2009) Leydig cell aging and the mechanisms of reduced tes-
tosterone synthesis. Mol. Cell. Endocrinol. 299, 23–31
12. Majdic, G., Millar, M. R., and Saunders, P. T. (1995) Immuno-
localisation of androgen receptor to interstitial cells in fetal rat
testes and to mesenchymal and epithelial cells of associated
ducts. J. Endocrinol. 147, 285–293
13. Shan, L. X., Zhu, L. J., Bardin, C. W., and Hardy, M. P. (1995)
Quantitative analysis of androgen receptor messenger ribonu-
cleic acid in developing Leydig cells and Sertoli cells by in situ
hybridization. Endocrinology 136, 3856–3862
14. Eisenberg, M. L., Jensen, T. K., Walters, R. C., Skakkebaek, N. E.,
and Lipshultz, L. I. (2012) The relationship between anogenital
distance and reproductive hormone levels in adult men. J. Urol.
187, 594–598
15. Drake, A. J., van den Driesche, S., Scott, H. M., Hutchison, G. R.,
Seckl, J. R., and Sharpe, R. M. (2009) Glucocorticoids amplify
dibutyl phthalate-induced disruption of testosterone production
and male reproductive development. Endocrinology 150, 5055–
5064
16. Kilcoyne, K., Smith, L., Atanassova, N., Macpherson, S., McKinnell,
C., van den Driesche, S., Jobling, M. S., Chambers, T., de Gendt,
K., Verhoeven, G., O’Hara, L., Platts, S., Renato de Franca, L.,
Lara, N., Anderson, R., and Sharpe, R. (2014) Fetal pro-
gramming of adult Leydig cell function via androgenic effects on
stem/progenitor cells. Proc. Natl. Acad. Sci. USA 111, E1924–
E1932
17. Payne, A. H., and Hardy, M. P. (2007) The Leydig Cell in Health
and Disease, Humana Press, Totowa, NJ
18. Lyon, M. F., and Hawkes, S. G. (1970) X-linked gene for testic-
ular feminization in the mouse. Nature 227, 1217–1219
19. O’Shaughnessy, P. J., Johnston, H., Willerton, L., and Baker, P. J.
(2002) Failure of normal adult Leydig cell development in
androgen-receptor-deﬁcient mice. J. Cell Sci. 115, 3491–3496
20. Murphy, L., and O’Shaughnessy, P. J. (1991) Testicular ste-
roidogenesis in the testicular feminized (Tfm) mouse: loss of 17
alpha-hydroxylase activity. J. Endocrinol. 131, 443–449
21. Goldstein, J. L., and Wilson, J. D. (1972) Studies on the patho-
genesis of the pseudohermaphroditism in the mouse with tes-
ticular feminization. J. Clin. Invest. 51, 1647–1658
22. Blackburn, W. R., Chung, K. W., Bullock, L., and Bardin, C. W.
(1973) Testicular feminization in the mouse: studies of Leydig
cell structure and function. Biol. Reprod. 9, 9–23
908 Vol. 29 March 2015 O’HARA ET AL.The FASEB Journal x www.fasebj.org
23. Murphy, L., and O’Shaughnessy, P. J. (1991) Effect of cryptor-
chidism on testicular and Leydig cell androgen production in
the mouse. Int. J. Androl. 14, 66–74
24. De Gendt, K., Swinnen, J. V., Saunders, P. T., Schoonjans, L.,
Dewerchin, M., Devos, A., Tan, K., Atanassova, N., Claessens, F.,
Le´cureuil, C., Heyns, W., Carmeliet, P., Guillou, F., Sharpe,
R. M., and Verhoeven, G. (2004) A Sertoli cell-selective knockout
of the androgen receptor causes spermatogenic arrest in meiosis.
Proc. Natl. Acad. Sci. USA 101, 1327–1332
25. McInnes, K. J., Smith, L. B., Hunger, N. I., Saunders, P. T.,
Andrew, R., and Walker, B. R. (2012) Deletion of the androgen
receptor in adipose tissue in male mice elevates retinol binding
protein 4 and reveals independent effects on visceral fat mass
and on glucose homeostasis. Diabetes 61, 1072–1081
26. O’Hara, L., and Smith, L. B. (2012) Androgen receptor signal-
ling in vascular endothelial cells is dispensable for spermato-
genesis and male fertility. BMC Res. Notes 5, 16
27. O’Hara, L., Welsh, M., Saunders, P. T., and Smith, L. B. (2011)
Androgen receptor expression in the caput epididymal epithe-
lium is essential for development of the initial segment and ep-
ididymal spermatozoa transit. Endocrinology 152, 718–729
28. Welsh, M., Moffat, L., Jack, L., McNeilly, A., Brownstein, D.,
Saunders, P. T., Sharpe, R. M., and Smith, L. B. (2010) Deletion
of androgen receptor in the smooth muscle of the seminal
vesicles impairs secretory function and alters its responsiveness to
exogenous testosterone and estradiol. Endocrinology 151, 3374–
3385
29. Welsh, M., Moffat, L., McNeilly, A., Brownstein, D., Saunders,
P. T., Sharpe, R. M., and Smith, L. B. (2011) Smooth muscle cell-
speciﬁc knockout of androgen receptor: a new model for pros-
tatic disease. Endocrinology 152, 3541–3551
30. Welsh, M., Saunders, P. T., Atanassova, N., Sharpe, R. M., and
Smith, L. B. (2009) Androgen action via testicular peritubular
myoid cells is essential for male fertility. FASEB J. 23, 4218–4230
31. Welsh, M., Sharpe, R. M., Moffat, L., Atanassova, N., Saunders,
P. T., Kilter, S., Bergh, A., and Smith, L. B. (2010) Androgen
action via testicular arteriole smooth muscle cells is important
for Leydig cell function, vasomotion and testicular ﬂuid dy-
namics. PLoS One 5, e13632
32. Smith, L. (2011) Good planning and serendipity: exploiting the
Cre/Lox system in the testis. Reproduction 141, 151–161
33. Xu, Q., Lin, H. Y., Yeh, S. D., Yu, I. C., Wang, R. S., Chen, Y. T.,
Zhang, C., Altuwaijri, S., Chen, L. M., Chuang, K. H., Chiang,
H. S., Yeh, S., and Chang, C. (2007) Infertility with defective
spermatogenesis and steroidogenesis in male mice lacking an-
drogen receptor in Leydig cells. Endocrine 32, 96–106
34. Jeyasuria, P., Ikeda, Y., Jamin, S. P., Zhao, L., De Rooij, D. G.,
Themmen, A. P., Behringer, R. R., and Parker, K. L. (2004) Cell-
speciﬁc knockout of steroidogenic factor 1 reveals its essential
roles in gonadal function. Mol. Endocrinol. 18, 1610–1619
35. He, W., Barak, Y., Hevener, A., Olson, P., Liao, D., Le, J., Nelson,
M., Ong, E., Olefsky, J. M., and Evans, R. M. (2003) Adipose-
speciﬁc peroxisome proliferator-activated receptor gamma
knockout causes insulin resistance in fat and liver but not in
muscle. Proc. Natl. Acad. Sci. USA 100, 15712–15717
36. Srinivas, S., Watanabe, T., Lin, C. S., William, C. M., Tanabe, Y.,
Jessell, T. M., and Costantini, F. (2001) Cre reporter strains
produced by targeted insertion of EYFP and ECFP into the
ROSA26 locus. BMC Dev. Biol. 1, 4
37. Eguchi, J., Wang, X., Yu, S., Kershaw, E. E., Chiu, P. C., Dushay, J.,
Estall, J. L., Klein, U., Maratos-Flier, E., and Rosen, E. D. (2011)
Transcriptional control of adipose lipid handling by IRF4. Cell
Metab. 13, 249–259
38. Tang, S. H., Silva, F. J., Tsark, W. M., and Mann, J. R. (2002) A
Cre/loxP-deleter transgenic line in mouse strain 129S1/SvImJ.
Genesis 32, 199–202
39. Welsh, M., Sharpe, R. M., Walker, M., Smith, L. B., and Saunders,
P. T. (2009) New insights into the role of androgens in wolfﬁan
duct stabilization in male and female rodents. Endocrinology 150,
2472–2480
40. O’Hara, L., York, J. P., Zhang, P., and Smith, L. B. (2014) Tar-
geting of GFP-Cre to the mouse Cyp11a1 locus both drives cre
recombinase expression in steroidogenic cells and permits gen-
eration of Cyp11a1 knock out mice. PLoS One 9, e84541
41. Tan, K. A., De Gendt, K., Atanassova, N., Walker, M., Sharpe,
R. M., Saunders, P. T., Denolet, E., and Verhoeven, G. (2005) The
role of androgens in sertoli cell proliferation and functional
maturation: studies in mice with total or Sertoli cell-selective
ablation of the androgen receptor. Endocrinology 146, 2674–2683
42. Baker, P. J., and O’Shaughnessy, P. J. (2001) Expression of
prostaglandin D synthetase during development in the mouse
testis. Reproduction 122, 553–559
43. Haisenleder, D. J., Schoenfelder, A. H., Marcinko, E. S., Geddis,
L. M., and Marshall, J. C. (2011) Estimation of estradiol in mouse
serum samples: evaluation of commercial estradiol immuno-
assays. Endocrinology 152, 4443–4447
44. Tyndall, V., Broyde, M., Sharpe, R., Welsh, M., Drake, A. J., and
McNeilly, A. S. (2012) Effect of androgen treatment during
foetal and/or neonatal life on ovarian function in prepubertal
and adult rats. Reproduction 143, 21–33
45. Smith, L. B., Milne, L., Nelson, N., Eddie, S., Brown, P.,
Atanassova, N., O’Bryan, M. K., O’Donnell, L., Rhodes, D., Wells,
S., Napper, D., Nolan, P., Lalanne, Z., Cheeseman, M., and
Peters, J. (2012) KATNAL1 regulation of sertoli cell microtubule
dynamics is essential for spermiogenesis and male fertility. PLoS
Genet. 8, e1002697
46. De Bruyn, R., Bollen, R., and Claessens, F. (2011) Identiﬁcation
and characterization of androgen response elements. Methods
Mol. Biol. 776, 81–93
47. McEwan, I. J. (2012) Intrinsic disorder in the androgen receptor:
identiﬁcation, characterisation and drugability. Mol. Biosyst. 8,
82–90
48. Chen, H., Ge, R. S., and Zirkin, B. R. (2009) Leydig cells: from
stem cells to aging. Mol. Cell. Endocrinol. 306, 9–16
49. Lee, K. Y., Russell, S. J., Ussar, S., Boucher, J., Vernochet, C.,
Mori, M. A., Smyth, G., Rourk, M., Cederquist, C., Rosen, E. D.,
Kahn, B. B., and Kahn, C. R. (2013) Lessons on conditional gene
targeting in mouse adipose tissue. Diabetes 62, 864–874
50. Martens, K., Bottelbergs, A., and Baes, M. (2010) Ectopic re-
combination in the central and peripheral nervous system by
aP2/FABP4-Cre mice: implications for metabolism research.
FEBS Lett. 584, 1054–1058
51. Raskin, K., de Gendt, K., Duittoz, A., Liere, P., Verhoeven, G.,
Tronche, F., and Mhaouty-Kodja, S. (2009) Conditional in-
activation of androgen receptor gene in the nervous system:
effects on male behavioral and neuroendocrine responses.
J. Neurosci. 29, 4461–4470
52. Hazra, R., Jimenez, M., Desai, R., Handelsman, D. J., and Allan,
C. M. (2013) Sertoli cell androgen receptor expression regulates
temporal fetal and adult Leydig cell differentiation, function,
and population size. Endocrinology 154, 3410–3422
53. Sharpe, R. M., Donachie, K., and Cooper, I. (1988) Re-evaluation
of the intratesticular level of testosterone required for quantita-
tive maintenance of spermatogenesis in the rat. J. Endocrinol. 117,
19–26
54. Anand-Ivell, R. J., Relan, V., Balvers, M., Coiffec-Dorval, I.,
Fritsch, M., Bathgate, R. A., and Ivell, R. (2006) Expression of the
insulin-like peptide 3 (INSL3) hormone-receptor (LGR8) system
in the testis. Biol. Reprod. 74, 945–953
55. Huang, Z., Rivas, B., and Agoulnik, A. I. (2012) Insulin-like 3
signaling is important for testicular descent but dispensable for
spermatogenesis and germ cell survival in adult mice. Biol.
Reprod. 87, 143
56. Faria, M. J., Simoes, Z. L., Lunardi, L. O., and Hartfelder, K.
(2003) Apoptosis process in mouse Leydig cells during postnatal
development. Microsc. Microanal. 9, 68–73
57. Beattie, M. C., Chen, H., Fan, J., Papadopoulos, V., Miller, P., and
Zirkin, B. R. (2013) Aging and luteinizing hormone effects on
reactive oxygen species production and DNA damage in rat
Leydig cells. Biol. Reprod. 88, 100
58. Li, X., Strauss, L., Kaatrasalo, A., Mayerhofer, A., Huhtaniemi, I.,
Santti, R., Ma¨kela¨, S., and Poutanen, M. (2006) Transgenic mice
expressing p450 aromatase as a model for male infertility asso-
ciated with chronic inﬂammation in the testis. Endocrinology 147,
1271–1277
59. Qian, Y. M., Sun, X. J., Tong, M. H., Li, X. P., Richa, J., and Song,
W. C. (2001) Targeted disruption of the mouse estrogen sulfo-
transferase gene reveals a role of estrogen metabolism in intra-
crine and paracrine estrogen regulation. Endocrinology 142,
5342–5350
60. Yu, W., Zheng, H., Lin, W., Tajima, A., Zhang, Y., Zhang, X.,
Zhang, H., Wu, J., Han, D., Rahman, N. A., Korach, K. S., Gao,
AR SIGNALING IN LEYDIG CELLS 909
G. F., Inoue, I., and Li, X. (2014) Estrogen promotes Leydig cell
engulfment by macrophages in male infertility. J. Clin. Invest. 124,
2709–2721
61. Rebourcet, D., O’Shaughnessy, P. J., Pitetti, J.-L., Monteiro, A.,
O’Hara, L., Milne, L., Tsai, Y.-T., Cruickshanks, L., Riethmacher,
D., Guillou, F., Mitchell, R., van ‘t Hof, R., Freeman, T., Nef, S.,
and Smith, L. (2014) Sertoli cells control peritubular myoid cell
fate and support adult Leydig cell development in the pre-
pubertal testis. Development 141, 2139–2149
62. De Gendt, K., Atanassova, N., Tan, K. A., de França, L. R., Parreira,
G. G., McKinnell, C., Sharpe, R. M., Saunders, P. T., Mason, J. I.,
Hartung, S., Ivell, R., Denolet, E., and Verhoeven, G. (2005)
Development and function of the adult generation of Leydig
cells in mice with Sertoli cell-selective or total ablation of the
androgen receptor. Endocrinology 146, 4117–4126
63. Jiang, M., Ma, Y., Chen, C., Fu, X., Yang, S., Li, X., Yu, G., Mao, Y.,
Xie, Y., and Li, Y. (2009) Androgen-responsive gene database: in-
tegrated knowledge on androgen-responsive genes.Mol. Endocrinol.
23, 1927–1933
64. Ochsner, S. A., Watkins, C. M., McOwiti, A., Xu, X., Darlington,
Y. F., Dehart, M. D., Cooney, A. J., Steffen, D. L., Becnel, L. B.,
and McKenna, N. J. (2012) Transcriptomine, a web resource for
nuclear receptor signaling transcriptomes. Physiol. Genomics 44,
853–863
65. Lague¨, E., and Tremblay, J. J. (2008) Antagonistic effects of tes-
tosterone and the endocrine disruptor mono-(2-ethylhexyl)
phthalate on INSL3 transcription in Leydig cells. Endocrinology
149, 4688–4694
66. Shima, Y., Miyabayashi, K., Haraguchi, S., Arakawa, T., Otake, H.,
Baba, T., Matsuzaki, S., Shishido, Y., Akiyama, H., Tachibana, T.,
Tsutsui, K., and Morohashi, K. (2013) Contribution of Leydig
and Sertoli cells to testosterone production in mouse fetal testes.
Mol. Endocrinol. 27, 63–73
67. O’Shaughnessy, P. J., Baker, P. J., Heikkila¨, M., Vainio, S., and
McMahon, A. P. (2000) Localization of 17beta-hydroxysteroid
dehydrogenase/17-ketosteroid reductase isoform expression in
the developing mouse testis—androstenedione is the major an-
drogen secreted by fetal/neonatal leydig cells. Endocrinology 141,
2631–2637
68. Welsh, M., Moffat, L., Belling, K., de França, L. R., Segatelli,
T. M., Saunders, P. T., Sharpe, R. M., and Smith, L. B. (2012)
Androgen receptor signalling in peritubular myoid cells is es-
sential for normal differentiation and function of adult Leydig
cells. Int. J. Androl. 35, 25–40
69. Landreh, L., Stukenborg, J. B., So¨der, O., and Svechnikov, K.
(2013) Phenotype and steroidogenic potential of PDGFRa-
positive rat neonatal peritubular cells. Mol. Cell. Endocrinol. 372,
96–104
70. Kawamura, K., Kumagai, J., Sudo, S., Chun, S. Y., Pisarska, M.,
Morita, H., Toppari, J., Fu, P., Wade, J. D., Bathgate, R. A., and
Hsueh, A. J. (2004) Paracrine regulation of mammalian oocyte
maturation and male germ cell survival. Proc. Natl. Acad. Sci. USA
101, 7323–7328
71. Del Borgo, M. P., Hughes, R. A., Bathgate, R. A., Lin, F., Kawamura,
K., and Wade, J. D. (2006) Analogs of insulin-like peptide
3 (INSL3) B-chain are LGR8 antagonists in vitro and in vivo.
J. Biol. Chem. 281, 13068–13074
72. Yoshida, S. (2010) Stem cells in mammalian spermatogenesis.
Dev. Growth Differ. 52, 311–317
73. Brinster, C. J., Ryu, B. Y., Avarbock, M. R., Karagenc, L., Brinster,
R. L., and Orwig, K. E. (2003) Restoration of fertility by germ cell
transplantation requires effective recipient preparation. Biol.
Reprod. 69, 412–420
74. Aggarwal, A., Misro, M. M., Maheshwari, A., Sehgal, N., and
Nandan, D. (2009) Adverse effects associated with persistent
stimulation of Leydig cells with hCG in vitro.Mol. Reprod. Dev. 76,
1076–1083
75. Luo, L., Chen, H., Trush, M. A., Show, M. D., Anway, M. D., and
Zirkin, B. R. (2006) Aging and the brown Norway rat leydig cell
antioxidant defense system. J. Androl. 27, 240–247
76. Zumoff, B. (1988) Hormonal abnormalities in obesity. Acta Med.
Scand. Suppl. 723, 153–160
77. Wranicz, J. K., Cygankiewicz, I., Rosiak, M., Kula, P., Kula, K., and
Zareba, W. (2005) The relationship between sex hormones and
lipid proﬁle in men with coronary artery disease. Int. J. Cardiol.
101, 105–110
78. Suzuki, K., Ito, K., Ichinose, Y., Kurokawa, K., Suzuki, T., Imai, K.,
Yamanaka, H., and Honma, S. (1995) Endocrine environment of
benign prostatic hyperplasia: prostate size and volume are cor-
related with serum estrogen concentration. Scand. J. Urol. Nephrol.
29, 65–68
79. Song, W. C., Moore, R., McLachlan, J. A., and Negishi, M. (1995)
Molecular characterization of a testis-speciﬁc estrogen sulfo-
transferase and aberrant liver expression in obese and di-
abetogenic C57BL/KsJ-db/db mice. Endocrinology 136, 2477–
2484
80. Tong, M. H., and Song, W. C. (2002) Estrogen sulfotransferase:
discrete and androgen-dependent expression in the male re-
productive tract and demonstration of an in vivo function in the
mouse epididymis. Endocrinology 143, 3144–3151
81. Tong, M. H., Jiang, H., Liu, P., Lawson, J. A., Brass, L. F., and
Song, W. C. (2005) Spontaneous fetal loss caused by placental
thrombosis in estrogen sulfotransferase-deﬁcient mice. Nat. Med.
11, 153–159
82. Qian, Y. M., and Song, W. C. (1999) Regulation of estrogen
sulfotransferase expression in Leydig cells by cyclic adenosine
39,59-monophosphate and androgen. Endocrinology 140, 1048–
1053
83. Flouriot, G., Brand, H., Denger, S., Metivier, R., Kos, M., Reid, G.,
Sonntag-Buck, V., and Gannon, F. (2000) Identiﬁcation of a new
isoform of the human estrogen receptor-alpha (hER-alpha) that
is encoded by distinct transcripts and that is able to repress hER-
alpha activation function 1. EMBO J. 19, 4688–4700
84. Simanainen, U., McNamara, K., Gao, Y. R., McPherson, S., Desai,
R., Jimenez, M., and Handelsman, D. J. (2011) Anterior prostate
epithelial AR inactivation modiﬁes estrogen receptor expression
and increases estrogen sensitivity. Am. J. Physiol. Endocrinol. Metab.
301, E727–E735
85. Yu, I. C., Lin, H. Y., Liu, N. C., Wang, R. S., Sparks, J. D., Yeh, S.,
and Chang, C. (2008) Hyperleptinemia without obesity in male
mice lacking androgen receptor in adipose tissue. Endocrinology
149, 2361–2368
86. Hughes, I. A., Davies, J. D., Bunch, T. I., Pasterski, V.,
Mastroyannopoulou, K., and MacDougall, J. (2012) Androgen
insensitivity syndrome. Lancet 380, 1419–1428
Received for publication April 25, 2014.
Accepted for publication October 20, 2014.
910 Vol. 29 March 2015 O’HARA ET AL.The FASEB Journal x www.fasebj.org
